GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Study Official
Genmab
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
76 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Rigshospitalet (copenhagen University Hospital)
Copenhagen, Denmark
- Herlev University Hospital
Herlev, Denmark
- University Hospital of Southern Denmark, Vejle Hospital
Vejle, Denmark
- Centre Hospitalier Universitaire de Bordeaux
Bordeaux, France
- Centre Antoine Lacassagne
Nice, France
- Gustave Roussy
Villejuif, France
- Arensia Research Clinic at the Research Institute of Clinical Medicine
Tbilisi, Georgia
- Nationales Centrum Fr Tumorerkrankungen Nct
Heidelberg, Germany
- Klinikum Der Stadt Ludwigshafen Am Rhein Ggmbh
Ludwigshafen, Germany
- Department of Dermatology, University of Mainz
Mainz, Germany
- Universitã¤tsmedizin Mannheim Dermatologie
Mannheim, Germany
- Universitaetsklinikum Wuerzburg
Würzburg, Germany
- Rabin Medical Center
Petah Tikva, Israel
- Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
- Azienda Ospedaliera Spedali Civili Di Brescia
Brescia, Italy
- Azienda Ospedaliera S.Croce E Carle Cuneo
Cuneo, Italy
- Istituto Nazionale Dei Tumori
Milan, Italy
- Istituto Clinico Humanitas
Rozzano, Italy
- Arensia Research Clinic at the Oncology Institute
Chisinau, Moldova
- Chungbuk National University Hospital
Cheongju-si, South Korea
- Jeonbuk National University Hospital
Jeonju, South Korea
- Gachon University Gil Medical Center
Namdong, South Korea
- Korea University Guro Hospital
Seoul, South Korea
- Samsung Medical Center
Seoul, South Korea
- Severance Hospital, Yonsei University Health System
Seoul, South Korea
- Pusan National University Yangsan Hospital
Yangsan, South Korea
- H. Vall D'Hebron
Barcelona, Spain
- Start Barcelona Hm Nou Delfos
Barcelona, Spain
- Hospital Duran I Reynals - Ico L Hospitalet
L'Hospitalet de Llobregat, Spain
- Hospital Universitario Insular de Gran Canaria
Las Palmas de Gran Canaria, Spain
- Hospital Universitario Lucus Augusti
Lugo, Spain
- Clinica Universidad de Navarra
Madrid, Spain
- Hm Ciocc Hospital Universitario Hm Sanchinarro
Madrid, Spain
- Hospital Clinico San Carlos
Madrid, Spain
- Hospital General Universitario Gregorio Maran
Madrid, Spain
- Hospital Universitario 12 de Octubre
Madrid, Spain
- Hospital Universitario la Paz
Madrid, Spain
- Hospital Universitario Ramon Y Cajal
Madrid, Spain
- Md Anderson Cancer Center Madrid
Madrid, Spain
- Start Madrid - Hospital Universitario Fundacion Jimenez Diaz
Madrid, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Sept 2019
- Primary completion
- 30 Dec 2025
- Completion
- 31 Jan 2027
- Last update posted
- 7 Jul 2026
- Registered enrollment
- 350
- Registry id
- NCT04083599
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.